Calendar

pharmadog

Week of Feb 23, 2026

Feb 24, 2026approval171d agoROBINUL (GLYCOPYRROLATE) — FDA approvalGLYCOPYRROLATE

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →GLYCOPYRROLATE →fda approvals ↗

Feb 24, 2026approval171d agoCLOMIPHENE CITRATE — FDA approvalCLOMIPHENE CITRATE

Sponsor: COSETTE. Form: TABLET. Route: ORAL

full page →CLOMIPHENE CITRATE →fda approvals ↗

Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoLURASIDONE HYDROCHLORIDE — FDA approvalSumitomo Pharma America Inc

Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMICAFUNGIN SODIUM — FDA approvalMICAFUNGIN SODIUM

Sponsor: YICHANG HUMANWELL. Form: INJECTABLE. Route: INTRAVENOUS

full page →MICAFUNGIN SODIUM →fda approvals ↗

Feb 24, 2026approval171d agoFOLLISTIM AQ (FOLLITROPIN ALFA/BETA) — FDA approvalfollitropin beta

Sponsor: ORGANON USA LLC. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →follitropin beta →fda approvals ↗

Feb 24, 2026approval171d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

Sponsor: AUROBINDO PHARMA LTD. Form: CAPSULE. Route: ORAL

full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗

Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalSaxenda

Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

full page →Saxenda →fda approvals ↗

Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

full page →encorafenib →fda approvals ↗

Feb 24, 2026approval171d agoBRAFTOVI (ENCORAFENIB) — FDA approvalencorafenib

Sponsor: ARRAY BIOPHARMA INC. Form: CAPSULE. Route: ORAL

full page →encorafenib →fda approvals ↗

Feb 24, 2026approval171d agoPREGABALIN — FDA approvalViatris Inc

Sponsor: FOURRTS LABS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoMUPIROCIN — FDA approvalFougera Pharmaceuticals Inc

Sponsor: FOUGERA PHARMS. Form: OINTMENT. Route: TOPICAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoGABAPENTIN — FDA approvalAlmatica Pharma LLC

Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 24, 2026approval171d agoLIRAGLUTIDE — FDA approvalNovo Nordisk Inc

Sponsor: ORBICULAR. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 24, 2026grant171d agoWASHINGTON UNIVERSITY — Dissecting the Impact of HIV-Induced Immunometabolic Perturbation on Tubercul...

AI grant. $427,623. PI: George Kyei

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF CONNECTICUT STORRS — Role of Alternate Ribosome Binding in Pathogenesis

AI grant. $447,604. PI: VICTORIA L ROBINSON

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF VIRGINIA — Pathogenesis of the concentric hypertrophy of the kidney arteriolesUniversity of Virginia

DK grant. $797,878. PI: ROBERTO Ariel GOMEZ

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF CALIFORNIA SANTA CRUZ — The multifaceted pathways of astrovirus entry and egress

GM grant. $422,677. PI: Valerie Cortez

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Technology knowledge optimization for type 1 diabetes in schools (TeKnO T1D: ...

NR grant. $472,950. PI: Christine March

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF OREGON — Molecular Mechanisms of Antimicrobial Resistance from Machine Learning Augmen...

GM grant. $401,285. PI: Dhiman Ray

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF ROCHESTER — Influence of pregnancy and the gut microbiome on methylmercury metabolism and...University of Rochester

ES grant. $415,613. PI: MATTHEW D RAND

full page →nih reporter ↗

Feb 24, 2026grant171d agoMAYO CLINIC ROCHESTER — Regulation of target cell survival by TBK1 and IKKeMayo Clinic

AI grant. $624,521. PI: ADRIAN T TING

full page →nih reporter ↗

Feb 24, 2026grant171d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Camptothecin analogs as "block and lock" agents for HIVUniversity of California San Diego

AI grant. $718,637. PI: Nadejda S Beliakova-Bethell

full page →nih reporter ↗

Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoSAXENDA (LIRAGLUTIDE) — FDA approvalNovo Nordisk Inc

Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoZIOPTAN (TAFLUPROST) — FDA approvaltafluprost

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →tafluprost →fda approvals ↗

Feb 25, 2026approval170d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ZEPBOUND →fda approvals ↗

Feb 25, 2026approval170d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval170d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalBioXcel Therapeutics, Inc.

Sponsor: DR REDDYS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Feb 25, 2026approval170d agoHYDROCORTISONE — FDA approvalET-800

Sponsor: APPCO. Form: TABLET. Route: ORAL

full page →ET-800 →fda approvals ↗

Feb 25, 2026approval170d agoCETIRIZINE HYDROCHLORIDE — FDA approvalCETIRIZINE HYDROCHLORIDE

Sponsor: RUBICON RESEARCH. Form: SOLUTION. Route: ORAL

full page →CETIRIZINE HYDROCHLORIDE →fda approvals ↗

Feb 25, 2026approval170d agoBUPROPION HYDROCHLORIDE — FDA approvalSenores Pharmaceuticals Inc

Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval170d agoEVEROLIMUS — FDA approvalPostsurgical Therapeutics Inc

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

Sponsor: BEIJING YILING. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

Sponsor: RISING. Form: TABLET. Route: ORAL

full page →ondansetron hydrochloride CR →fda approvals ↗

Feb 25, 2026approval170d agoENTYVIO (VEDOLIZUMAB) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Feb 25, 2026approval170d agoJUXTAPID (LOMITAPIDE MESYLATE) — FDA approvalChiesi USA Inc

Sponsor: CHIESI. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Feb 25, 2026approval170d agoDESMODA (DESMOPRESSIN ACETATE) — FDA approvaldesmopressin acetate

Sponsor: ETON. Form: SOLUTION. Route: ORAL

full page →desmopressin acetate →fda approvals ↗

Feb 25, 2026approval170d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: ALEMBIC. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Feb 25, 2026grant170d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Advancing Cardiovascular Health Among Adolescents with Intellectual Disabilit...

NR grant. $169,189. PI: Patricia Marie West

full page →nih reporter ↗

Feb 25, 2026grant170d agoUNIVERSITY OF COLORADO DENVER — Understanding the contributions of MAIT cells in colitisUniversity of Colorado Denver

AI grant. $429,000. PI: Li Yen Loh

full page →nih reporter ↗

Feb 25, 2026grant170d agoKEYSTONE SYMPOSIA — B and T Cell Collaboration in Lymphoid and Nonlymphoid Microenvironments

AI grant. $14,000. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Feb 25, 2026grant170d agoKEYSTONE SYMPOSIA — B Cells and Plasma Cells: Fundamental and Translational Biology

AI grant. $15,500. PI: TERRY L. SHEPPARD

full page →nih reporter ↗

Feb 25, 2026grant170d agoFLORIDA STATE UNIVERSITY — Multi-level factors influencing maternal and infant health outcomes

HD grant. $540,915. PI: Patricia Ann Homan

full page →nih reporter ↗

Feb 25, 2026grant170d agoMAYO CLINIC JACKSONVILLE — Role of meningeal lymphatic drainage in CSF1R-related leukoencephalopathyMayo Clinic

NS grant. $50,114. PI: Guadalupe Sanchez

full page →nih reporter ↗

Feb 26, 2026approval169d agoXeomin (incobotulinumtoxinA) — FDA approvalMerz Pharmaceuticals LLC

Sponsor: MERZ PHARMS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

← prev

page 1 of 40

Week of Feb 23, 2026